CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | Maduck Sean See Remarks | Sale 10b5-1 | −16,394 | $85.06 | $1.4M | 10,551 |
| 2025-10-01 | Maduck Sean See Remarks | Sale 10b5-1 | −2,647 | $85.58 | $227K | 7,904 |
| 2025-10-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −1,986 | 0 | ||
| 2025-10-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −18,014 | 281,986 | ||
| 2025-09-19 | Guyer William Chief Development Officer | Gift | −200 | 5,287 | ||
| 2025-09-10 | Cannon Gillian Director | Gift | −7,393 | 0 | ||
| 2025-09-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $14.08 | $31K | 2,200 |
| 2025-09-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $72.45 | $159K | 0 |
| 2025-09-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 3,300 | ||
| 2025-09-04 | Cannon Gillian Director | Option exercise | +11,000 | $22.99 | $253K | 11,000 |
| 2025-09-04 | Cannon Gillian Director | Shares withheld for taxes | −3,607 | $70.13 | $253K | 7,393 |
| 2025-09-04 | Cannon Gillian Director | Option exercise · Stock option (right to buy) | −11,000 | 49,000 | ||
| 2025-09-03 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes 10b5-1 | −189 | $71.38 | $13K | 10,277 |
| 2025-09-03 | Maduck Sean See Remarks | Shares withheld for taxes 10b5-1 | −233 | $71.38 | $17K | 7,904 |
| 2025-09-03 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −144 | $71.38 | $10K | 14,321 |
| 2025-09-03 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −256 | $71.38 | $18K | 13,610 |
| 2025-09-02 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 25,487 |
| 2025-09-02 | Guyer William Chief Development Officer | Sale 10b5-1 | −15,594 | $70.39 | $1.1M | 9,893 |
| 2025-09-02 | Guyer William Chief Development Officer | Sale 10b5-1 | −4,406 | $70.85 | $312K | 5,487 |
| 2025-09-02 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 330,000 |
Page 19 of 61 · 1,220 trades